share_log

Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $114 Price Target

Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $114 Price Target

Barrington研究保持對merit medical systems的跑贏市場評級,維持114美元的目標股價
Benzinga ·  2024/10/31 21:34  · 評級/大行評級

Barrington Research analyst Michael Petusky maintains Merit Medical Systems (NASDAQ:MMSI) with a Outperform and maintains $114 price target.

Barrington Research分析師Michael Petusky表示,維持merit medical systems(納斯達克:MMSI)的表現,並保持目標股價在114美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論